Navigation Links
GenWay Biotech's You Test You puts early cancer detection tool in the hands of consumers
Date:3/1/2010

San Diego-based GenWay Biotech, Inc. today announced the availability of the You Test You Cancer Assessment that allows patients to test for various types of cancer without having to visit their doctor's office, through a simple blood sample. With a 10-day turnaround time and a cost of $149, You Test You is a convenient and low cost way to periodically test for indication of cancer.

The test can be ordered online through the www.youtestyou.com Web site. The patient completes an online form, which is reviewed by a You Test You doctor. Upon approval, the patient visits a local laboratory to have a blood sample taken. You Test You is an easily accessible and effective method for detecting evidence of cancer, which may lead to diagnosing and treating cancer earlier. Diagnosing cancer in the early stages can lead to successful treatment and an increased survival rate.

"The American Cancer Society has stressed the importance of early cancer detection, yet for various reasons, many Americans do not have regular checkups with their doctors", said GenWay CEO Robert Gans. "This convenient and inexpensive test will provide a valuable means for patients to be proactive and evaluate certain proteins found in the blood which are frequently associated with most cancers"

George Delgado, M.D., specialist in family medicine and voluntary associate clinical professor at UC San Diego says, "The You Test You Cancer Assessment is a great test for people who want to take charge of their health and make better health decisions."

The launch of You Test You is particularly timely, given recent recommendations from various sources setting guidelines for both breast and cervical cancer screening. The test is the first of its kind for cancer, helping patients monitor their own health. In addition to the lab-based test, a home sample collection kit will be available early this year.

According to Sergey Sikora, GenWay's Vice President of Business Development, "You Test You is a step toward putting health care into the hands of patients, many of whom do not have the time or money for expensive cancer testing. We are proud to offer a test that, with a prescription from our doctor, is widely accessible to the general consumer."


'/>"/>

Contact: Jill Dombrauckas
jdom@genwaybio.com
858-458-0866 x119
GenWay Biotech
Source:Eurekalert

Related biology news :

1. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
2. General tumor marker test now offered by GenWay clinical laboratory
3. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
4. 60 second test could help early diagnosis of common brain diseases
5. Restless legs syndrome affects nearly 2 percent of US/UK children
6. Bleeding, not inflammation, is major cause of early lung infection death
7. Pig study sheds new light on the colonisation of Europe by early farmers
8. Color contrast is seen by the brain early doors
9. Extra gene copies were enough to make early humans mouths water
10. Was ability to run early mans Achilles heel?
11. New technique can be breakthrough for early cancer diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017 The report "Gesture Recognition and Touchless ... and Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is ... of 29.63% between 2017 and 2022. Continue Reading ... ... ...
(Date:3/20/2017)... 20, 2017 At this year,s CeBIT Chancellor Dr. ... manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with the ... year,s CeBIT partner country. At the largest German biometrics company the two ... face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... York , March 23, 2017 According ... plasma products and derivatives market is fragmented due to the presence of ... such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with ... these three companies, collectively, held more than 76% of this market ... As ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... COPENHAGEN, Denmark , March 22, 2017 /PRNewswire/ ... that utilizes its innovative TransCon technology to address ... announced financial results for the full year ended ... a significant year for our company as we ... become a leading, integrated rare disease company with ...
Breaking Biology Technology: